No known drug interactions for the matched ingredients — not a guarantee none exist. Check your meds →
Dietary supplement

PhosphaLine Ingredients & Drug Interactions

by XYMOGEN

Softgel Capsule Category: Fat/fatty Acid
No known interaction
The interaction bottom line No known interaction

PhosphaLine is a dietary supplement by XYMOGEN with 1 active ingredient. Its ingredients are commonly taken for liver health, memory and brain support, ulcerative colitis.We don’t currently list a known drug interaction for its mapped ingredients — but that doesn’t guarantee none exist, so always confirm with your pharmacist.

HelloPharmacist Scorecard of PhosphaLine by XYMOGEN

Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.

From our pharmacy team — supplement deep dive

What’s inside

Full disclosure
Ingredient Transparency · database check
Full

Every active ingredient lists its own amount on the label.

Why this rating?
  • The label discloses an exact amount for 1 of its 1 active ingredient.
  • No proprietary blends here — you can verify the dose of every single component.

PhosphaLine has one active ingredient: polyenylphosphatidylcholine, a fat-soluble compound that's a building block of cell membranes. The softgel also contains glycerides, fatty acids, and ethanol as inactive ingredients to deliver it.

Does it work?

Moderate evidence
Evidence for Intended Use · database check
By FDA rules, dietary supplements can’t claim to treat, cure, or prevent disease — so labels speak in careful marketing language. We discern each product’s intended use from its name, label claims, and label statements, then grade the clinical evidence for that use. How these ratings are computed

This product doesn't appear to be marketed for a specific use, so we graded Phosphatidylcholine's overall clinical evidence instead.

Moderate

Some clinical evidence supports Phosphatidylcholine for:

Why this rating?
  • We looked at the product name, claims, and label statements and couldn't find a stated purpose to grade.
  • Since the label doesn't commit to one use, we graded the ingredient's overall clinical evidence instead.
  • On file: Ulcerative colitis — rated "Possibly Effective" (Natural Medicines).

The evidence is mixed. Polyenylphosphatidylcholine is possibly effective for ulcerative colitis (inflammatory bowel disease).

For nonalcoholic fatty liver disease, alcohol-related liver disease, Alzheimer disease, and anxiety, the evidence we hold is insufficient — we don't know yet whether it works for those uses.

The evidence, ingredient by ingredient Phosphatidylcholine

How safe is it?

Well-documented data
Safety Information · database check
Well characterized

Adverse-effect, pregnancy, and general safety data are on file for most of these ingredients.

Why this rating?
  • We hold adverse-effect (side-effect) data for 1 of the 1 matched ingredient.
  • Pregnancy & breastfeeding safety ratings cover 1 of 1.
  • General safety write-ups exist for 1 of 1.
  • Remember: this measures how much safety information exists. Thin data is not the same as being safe.

Polyenylphosphatidylcholine is generally well tolerated when taken by mouth. At high doses (30 grams per day or more), it can cause digestive upset and diarrhea; even smaller doses have triggered bloating, diarrhea, altered taste, nausea, and vomiting in some people.

You may also notice increased sweating or itching. Choline (which your body gets from this ingredient) is needed in pregnancy, but supplement safety beyond food sources isn't well studied — talk with your doctor before taking it if you're pregnant.

There isn't enough data on supplement use while breastfeeding; check with your healthcare provider first.

Side effects, ingredient by ingredient Phosphatidylcholine

Meds to double-check

No known interactions
Known Interaction Concern · database check
No known interactions

No medication interactions are currently documented for the matched ingredients — that isn't a guarantee none exist.

Why this rating?
  • None of the 1 matched ingredient has a documented medication interaction on file.

No interactions are documented in our data for the ingredient in this product. That said, run your exact medications through the search tool on this page before you start, and let your doctor or pharmacist know you're taking it.

The bottom line

Scorecard at a glanceFully disclosed formula with some supporting evidence behind its ingredients' uses. No medication interactions are currently documented, and safety information is well characterized.

PhosphaLine may be worth considering if you have ulcerative colitis and want to explore a possibly effective option. If you're pregnant, breastfeeding, or taking any medications, talk it over with your doctor or pharmacist first — they know your full picture and can tell you whether this is right for you.

Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI

Assessment coverage: 1 of 1 active ingredient matched to our full ingredient reviews (monographs). Based on the product label dated Dec 22, 2017.

This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed

At a glance

General information

Key facts about PhosphaLine, straight from the product label.

Brand XYMOGEN
Barcode (UPC) 871149001049
Net contents 300 Softgel(s)
Market status On market
Date entered into DSLD Dec 22, 2017
DSLD ID 81428
Product type Fat/fatty Acid
Supplement form Softgel Capsule
Dietary claims / uses Nutrient, All Other, Structure/Function
Intended target group(s) Adult (18 - 50 Years), Gluten Free, Dairy Free
From the label
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.

Supplement Facts

The label details for PhosphaLine by XYMOGEN, sourced from the NIH Dietary Supplement Label Database.

Supplement Facts

Daily Value (DV) Target Group(s):
Adults and children 4 or more years of age
Minimum serving Sizes:
3 Softgel(s)
Maximum serving Sizes:
3 Softgel(s)
Servings per container
100
UPC/BARCODE
871149001049
IngredientAmount% DV
Calories30 Calorie(s)--
Total Fat3 Gram(s)4%
Polyenylphosphatidylcholine2.7 Gram(s)--

Other ingredients: Glycerides and Fatty Acids, Softgel, Ethanol

Tap any ingredient to jump to its full detail below.

Label statements
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
General Statements

Professional use only

Unlike most other phosphatidylcholine products on the markets, PhosphaLine contains no other phospholipids, aside from PPC and DLPC, that may compete for absorption. Studies suggest that PPC ingestion increases choline levels in the blood and brain and supports acetylcholine synthesis for healthy brain and liver function, healthy cholesterol levels already within the normal range, and gastric mucosal protection. PPC is widely used to support healthy aging.

ePV Exclusive professional formulas

Scan to learn more! This package is completely recyclable

Brand IP Statement(s)

Not for resale on third-party websites, including, but not limited to, Amazon and eBay.

2016 XYMOGEN

Suggested/Recommended/Usage/Directions

Directions: Take two to three softgels daily, or as directed by your healthcare practitioner.

Precautions

Consult your healthcare practitioner prior to use.

Individuals taking medication should discuss potential interactions with their healthcare practitioner.

Do not use if tamper seal is damaged.

Storage: Keep tightly closed in a dry place at controlled room temperature 15(0)-30(0)C (59(0)-86(0)F), out of reach of children.

Contains: Soy.

Formula

PhosphaLine provides 2.7 g of pure polyenylphosphatidylcholine (PPC) per serving plus the highest concentrated source of 1,2 DLPC ( dilinoleoylphosphatidylcholine).

100% pure polyenylphosphatidylcholine concentrate

Contains: Soy.

Formulation

Unlike most other phosphatidylcholine products on the markets, PhosphaLine contains no other phospholipids, aside from PPC and DLPC, that may compete for absorption.

Does Not Contain: Wheat, gluten, yeast, dairy products, fish, shellfish, peanuts, tree nuts, egg, artificial colors, artificial sweeteners, or artificial preservatives.

FDA Disclaimer Statement

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Storage

Storage: Keep tightly closed in a dry place at controlled room temperature 15(0)-30(0)C (59(0)-86(0)F), out of reach of children.

FDA Statement of Identity

Dietary Supplement

General

ZLB-PHOS300-01 REV. 080516

Seals/Symbols

Third-Party GMP Compliant Verified

See for yourself

PhosphaLine by XYMOGEN label

The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.

What’s inside

The Ingredients in PhosphaLine by XYMOGEN

This is the 1 active ingredient this product is made of. Select it to open its full monograph.

Serving size3 Softgel(s) Dosage formSoftgel Capsule Servings per container100 Amounts shown are per serving.

Polyenylphosphatidylcholine

No known
interactions
2.7 Gram(s) per serving Form: Soybean Lecithin

Phosphatidylcholine is a phospholipid that is part of every cell membrane and a source of choline. People take it for liver, brain, and gut health, bu...

Polyenylphosphatidylcholine monograph & interactions

Other (inactive) ingredients: Glycerides and Fatty Acids, Softgel, Ethanol. These complete the product’s ingredient list but are not active constituents.

Interaction report

PhosphaLine by XYMOGEN Drug Interactions

We don’t currently list any known drug interactions for the mapped ingredients in PhosphaLine. This doesn’t guarantee none exist — always confirm with your pharmacist before combining a supplement with your medications.

The maker

Brand information

Manufacturer and brand details for PhosphaLine, from the product label.

XYMOGEN

See all XYMOGEN products
Name
XYMOGEN Exclusive Professional Formulas
Street Address
6900 Kingspointe Pkwy.
City
Orlando
State
FL
ZipCode
32819
Phone Number
800-647-6100
Web Address
www.xymogen.com
Pharmacist Counseling Corner

PhosphaLine by XYMOGEN: Common Questions

Does PhosphaLine by XYMOGEN interact with any medications?
We do not currently list a known interaction for the mapped ingredients in PhosphaLine. This does not guarantee none exist, so confirm with your pharmacist.
How can one product interact with so many drugs?
PhosphaLine contains a single active ingredient, and that one ingredient can interact with many different medications on its own. We check it against each medication and show the mechanism responsible.
Where does this information come from?
The product label data comes from the NIH Dietary Supplement Label Database (DSLD); the interaction data is built on the Natural Medicines database and reviewed by HelloPharmacist pharmacists.
What is polyenylphosphatidylcholine and what does it do?
It's a fat-soluble compound that makes up part of cell membranes throughout your body. Your cells naturally contain it, and it may help support cell structure and function — though the evidence for supplement use is still being studied.
Will this help my liver?
For nonalcoholic fatty liver disease and alcohol-related liver disease, we don't have enough reliable evidence yet to say whether it works. Talk with your doctor about whether it's worth trying for your specific situation.
What side effects should I watch for?
Most common are altered taste, bloating, diarrhea, nausea, and vomiting — especially at higher doses. You might also notice more sweating or itching. If any of these bother you, let your pharmacist or doctor know.
Is it safe to take if I'm pregnant?
Choline (which this product contains) is needed during pregnancy, but we don't have enough data on supplement safety beyond food sources. Check with your doctor before taking it if you're pregnant — they can advise you based on your needs.
Can I take this while breastfeeding?
There isn't enough reliable data to know whether it's safe while breastfeeding. Speak with your healthcare provider first to decide what's best for you and your baby.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Not sure if PhosphaLine is safe with your meds?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.

PhosphaLine label
Sources

Sources & How We Checked

PhosphaLine's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.

Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.

The 15 references behind this product’s interaction data

Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.

Phosphatidylcholine 15 references
  1. Domino EF, May WW, Demetriou S, et al. Lack of clinically significant improvement of patients with tardive dyskinesia following phosphatidylcholine therapy. Biol Psychiatry 1985;20:1189-96. PubMed
  2. Aronson PJ, Lorincz AL. Promotion of palmar sweating with oral phosphatidylcholine. Acta Derm Venereol 1985;65:19-24. DOI
  3. Hexsel DM, Serra M, de Oliveira Dal'Forno T, et al. Cosmetic uses of injectable phosphatidylcholine on the face. Otolaryngol Clin North Am 2005;38:1119-29. PubMed
  4. Kopera D, Binder B, Toplak H, et al. Histopathologic changes after intralesional application of phosphatidylcholine for lipoma reduction: report of a case. Am J Dermatopathol 2006;28:331-3. PubMed
  5. Rittes PG. The use of phosphatidylcholine for correction of lower lid bulging due to prominent fat pads. Dermatol Surg 2001;27:391-2. PubMed
  6. Rotunda AM, Kolodney MS. Mesotherapy and phosphatidylcholine injections: historical clarification and review. Dermatol Surg 2006;32:465-80. PubMed
  7. Hexsel D, Serra M, Mazzuco R, et al. Phosphatidylcholine in the treatment of localized fat. J Drugs Dermatol 2003;2:511-8.
  8. Hasengschwandtner F. Phosphatidylcholine treatment to induce lipolysis. Cosmet Dermatol 2005;4:308-13. PubMed
  9. Rittes PG. The use of phosphatidylcholine for correction of localized fat deposits. Aesthetic Plast Surg 2003;27:315-8. PubMed
  10. Ablon G, Rotunda AM. Treatment of lower eyelid fat pads using phosphatidylcholine: clinical trial and review. Dermatol Surg 2004;30:422-7. PubMed
  11. Loguercio C, Andreone P, Brisc C, et al. Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial. Free Radic Biol Med 2012;52(9):1658-65. PubMed
  12. Panos, J. M., Palson, R., Johnson, R., Portmann, B., and Williams, R. Polyunsaturated phosphatidylcholine for acute alcoholic hepatitis: a double blind randomized placebo controlled trial. Eur.J.Gastroenterol 1990;2:351-355.
  13. Stremmel W, Braun A, Hanemann A, Ehehalt R, Autschbach F, Karner M. Delayed release phosphatidylcholine in chronic-active ulcerative colitis: a randomized, double-blinded, dose finding study. J Clin Gastroenterol 2010;44(5):e101-7. PubMed
  14. Stremmel W, Ehehalt R, Autschbach F, Karner M. Phosphatidylcholine for steroid-refractory chronic ulcerative colitis: a randomized trial. Ann Intern Med. 2007;147(9):603-10. PubMed
  15. Stremmel W, Vural H, Evliyaoglu O, Weiskirchen R. Delayed Release Phosphatidylcholine is Effective for Treatment of Ulcerative Colitis: A Meta-Analysis. Dig Dis 2021;39(5):508-515. PubMed

See these in context on the Phosphatidylcholine monograph →

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep exploring